Amati AIM VCT (AMAT) Competitors GBX 74.50 -1.00 (-1.32%) (As of 11/18/2024 09:22 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlines AMAT vs. IPF, APH, SGM, MSI, BERI, MCP, STM, ATOM, MIND, and INSGShould you be buying Amati AIM VCT stock or one of its competitors? The main competitors of Amati AIM VCT include International Personal Finance (IPF), Alliance Pharma (APH), Sigma Capital Group (SGM), MS INTERNATIONAL (MSI), BlackRock Energy and Resources (BERI), Martin Currie Asia Unconstrand Trust (MCP), STM Group (STM), Atome (ATOM), Mind Gym (MIND), and Insig AI (INSG). These companies are all part of the "electronic equipment" industry. Amati AIM VCT vs. International Personal Finance Alliance Pharma Sigma Capital Group MS INTERNATIONAL BlackRock Energy and Resources Martin Currie Asia Unconstrand Trust STM Group Atome Mind Gym Insig AI International Personal Finance (LON:IPF) and Amati AIM VCT (LON:AMAT) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, community ranking, profitability, earnings and risk. Which has more volatility and risk, IPF or AMAT? International Personal Finance has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Comparatively, Amati AIM VCT has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500. Does the media favor IPF or AMAT? In the previous week, International Personal Finance had 1 more articles in the media than Amati AIM VCT. MarketBeat recorded 1 mentions for International Personal Finance and 0 mentions for Amati AIM VCT. International Personal Finance's average media sentiment score of 0.88 beat Amati AIM VCT's score of 0.00 indicating that International Personal Finance is being referred to more favorably in the media. Company Overall Sentiment International Personal Finance Positive Amati AIM VCT Neutral Do analysts prefer IPF or AMAT? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score International Personal Finance 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Amati AIM VCT 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in IPF or AMAT? International Personal Finance received 363 more outperform votes than Amati AIM VCT when rated by MarketBeat users. However, 70.83% of users gave Amati AIM VCT an outperform vote while only 66.09% of users gave International Personal Finance an outperform vote. CompanyUnderperformOutperformInternational Personal FinanceOutperform Votes38066.09% Underperform Votes19533.91% Amati AIM VCTOutperform Votes1770.83% Underperform Votes729.17% Is IPF or AMAT more profitable? International Personal Finance has a net margin of 6.45% compared to Amati AIM VCT's net margin of 0.00%. International Personal Finance's return on equity of 10.39% beat Amati AIM VCT's return on equity.Company Net Margins Return on Equity Return on Assets International Personal Finance6.45% 10.39% 8.81% Amati AIM VCT N/A -7.38%-4.56% Which has stronger valuation & earnings, IPF or AMAT? International Personal Finance has higher revenue and earnings than Amati AIM VCT. Amati AIM VCT is trading at a lower price-to-earnings ratio than International Personal Finance, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInternational Personal Finance£759.50M0.38£49M£0.20667.50Amati AIM VCT-£8M-13.74-£10.96M-£0.07-1,064.29 Do insiders and institutionals hold more shares of IPF or AMAT? 91.6% of International Personal Finance shares are owned by institutional investors. 8.9% of International Personal Finance shares are owned by company insiders. Comparatively, 0.5% of Amati AIM VCT shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is IPF or AMAT a better dividend stock? International Personal Finance pays an annual dividend of GBX 11 per share and has a dividend yield of 8.2%. Amati AIM VCT pays an annual dividend of GBX 5 per share and has a dividend yield of 6.7%. International Personal Finance pays out 5,500.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Amati AIM VCT pays out -7,142.9% of its earnings in the form of a dividend. SummaryInternational Personal Finance beats Amati AIM VCT on 17 of the 19 factors compared between the two stocks. Ad Porter & CompanyFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Get Amati AIM VCT News Delivered to You Automatically Sign up to receive the latest news and ratings for AMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMAT vs. The Competition Export to ExcelMetricAmati AIM VCTAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£109.91M£785.19M£2.87B£1.38BDividend Yield6.54%13.41%4.62%11.73%P/E Ratio-1,064.29765.67441.541,558.19Price / Sales-13.7413,749.383,294.08210,813.20Price / Cash2.9179.4948.5332.93Price / Book0.851.701.452.80Net Income-£10.96M£55.38M£365.88M£152.70M7 Day Performance-1.32%10.75%6.65%3.93%1 Month Performance-2.61%-0.51%0.22%2.48%1 Year Performance-16.76%11.38%15.91%119.05% Amati AIM VCT Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMATAmati AIM VCTN/AGBX 74.50-1.3%N/A-15.6%£109.91M£-8,000,000.00-1,064.2933,000IPFInternational Personal FinanceN/AGBX 135+3.4%N/A+11.4%£294.49M£759.50M675.006,230APHAlliance Pharma2.622 of 5 starsGBX 46.70+1.4%N/A+30.2%£252.45M£183.15M-778.3391,000Gap UpSGMSigma Capital GroupN/AGBX 202flatN/AN/A£181.35M£10.60M54.5948,300MSIMS INTERNATIONALN/AGBX 1,116-1.7%N/A+28.0%£178.45M£109.58M1,665.67455Gap DownBERIBlackRock Energy and ResourcesN/AGBX 119.50-1.0%N/A+8.8%£145.90M£27.41M663.89N/AMCPMartin Currie Asia Unconstrand TrustN/AGBX 414+0.6%N/A+0.0%£145.58M£6.14M43.1321,000STMSTM GroupN/AGBX 61.50flatN/A+11.8%£35.53M£30.06M3,075.0048,300ATOMAtome2.3851 of 5 starsGBX 55.25+0.5%N/A-32.3%£24.82MN/A-460.4220MINDMind GymN/AGBX 19+5.6%N/A-53.7%£19.07M£44.91M-172.73270Gap UpINSGInsig AIN/AGBX 14-1.8%N/A-25.9%£16.49M£2.02M-77.78410 Related Companies and Tools Related Companies International Personal Finance Competitors Alliance Pharma Competitors Sigma Capital Group Competitors MS INTERNATIONAL Competitors BlackRock Energy and Resources Competitors Martin Currie Asia Unconstrand Trust Competitors STM Group Competitors Atome Competitors Mind Gym Competitors Insig AI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:AMAT) was last updated on 11/19/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amati AIM VCT Please log in to your account or sign up in order to add this asset to your watchlist. Share Amati AIM VCT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
